Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice

Journal of Lipid Research

Volumn 44, Issue 1, 2003, Pages 33-40

  Cazita, Patrícia M ^a   Berti, Jairo A ^a   Aoki, Carolina ^a   Gidlund, Magnus ^a   Harada, Lila M ^a   Nunes, Valéria S ^a   Quintão, Eder C R ^a   Oliveira, Helena C F ^a  

^a NONE

Author keywords

CETP transgenic mice; Estrogen; LDL receptor knockout mice; Lecithin cholesterol acyl transferase; Oxidized LDL; Phospholipid transfer protein

Indexed keywords

ANTIBODY; CHOLESTEROL ESTER TRANSFER PROTEIN; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0037242999     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M100440-JLR200     Document Type: Article

References (55)

1. Bruce, C., R. A. Chouinard, Jr., and A. R. Tall. 1998. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu. Rev. Nutr 18: 297-330.
2. Inazu, A., J. Koizumi, and H. Mabuchi. 2000. Cholesteryl ester transfer protein and atherosclerosis. Curr. Opin. Lipidol. 11: 389-396.
3. Zhong, S., D. S. Sharp, J. S. Grove, C. Bruce, K. Yano, J. D. Curb, and A. R. Tall. 1996. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97: 2917-2923.
4. Bhatnagar, D., P. N. Durrington, K. M. Channon, H. Prais, and M. I. Mackness. 1993. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis. 98: 25-32.
5. Marotti, K. R., C. K. Castle, T. P. Boyle, A. H. Lin, R. W. Murray, and G. W. Melchior. 1993. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 364: 73-75.
6. Plump, A. S., L. Masucci-Magoulas, C. Bruce, C. L. Bisgaier, J. L. Breslow, and A. R. Tall. 1999. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler. Thromb. Vasc. Biol. 19: 1105-1110.
7. Hayek, T., L. Masucci-Magoulas, X. Jiang, A. Walsh, E. Rubin, J. L. Breslow, and A. R. Tall. 1995. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96: 2071-2074.
8. Foger, B., M. Chase, M. J. Amar, B. L. Vaisman, R. D. Shamburek, B. Paigen, J. Fruchart-Najib, J. A. Paiz, C. A. Koch, R. F. Hoyt, H. B. Brewer, Jr., and S. Santamarina-Fojo. 1999. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J. Biol. Chem. 274: 36912-36920.
9. Sugano, M., N. Makino, S. Sawada, S. Otsuka, M. Watanabe, H. Okamoto, M. Kamada, and A. Mizushima. 1998. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J. Biol. Chem. 273: 5033-5036.
10. Okamoto, H., F. Yonemori, K. Wakitani, T. Minowa, K. Maeda, and H. Shinkai. 2000. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature. 406: 203-207.
11. Rittershaus, C. W., D. P. Miller, L. J. Thomas, M. D. Picard, C. M. Honan, C. D. Emmett, C. L. Pettey, H. Adari, R. A. Hammond, D. T. Beattie, A. D. Callow, H. C. Marsh, and U. S. Ryan. 2000. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb. Vasc. Biol. 20: 2106-2112.
12. Hirano, K., S. Yamashita, and Y. Matsuzawa. 2000. Pros and cons of inhibiting cholesteryl ester transfer protein. Curr Opin. Lipidol. 11: 589-596.
13. Thompson, G. R., and P.J. Barter. 2000. Therapeutic approaches to reducing the LDL- and HDL-associated risks of coronary heart disease. Curr. Opin. Lipidol. 11: 567-570.
14. Wenger, N. K. 1999. Postmenopausal hormone use for cardioprotection: what we know and what we must learn. Curr. Opin. Cardiol. 14: 292-297.
15. Vadlamudi, S., P. MacLean, T. Green, N. Shukla, J. Bradfield, S. Vore, and H. Barakat. 1998. Role of female sex steroids in regulating cholesteryl ester transfer protein in transgenic mice. Metabolism. 47: 1048-1051.
16. Tilly-Kiesi, M., J. Kahri, T. Pyorala, J. Puolakka, H. Luotola, M. Lappi, S. Lahdenpera, and M. R. Taskinen. 1997. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women. Atherosclerosis. 129: 249-259.
17. Zuckerman, S. H., G. F. Evans, J. A. Schelm, P. I. Eacho, and G. Sandusky. 1999. Estrogen-mediated increases in LDL cholesterol and foam cell-containing lesions in human ApoB100xCETP transgenic mice. Arterioscler. Thromb. Vasc. Biol. 19: 1476-1483.
18. Ishibashi, S., J. L. Goldstein, M. S. Brown, J. Herz, and D. K. Burns. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93: 1885-1893.
19. Tangirala, R. K., E. M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36: 2320-2328.
20. Jiang, X. C., L. B. Agellon, A. Walsh, J. L. Breslow, and A. Tall. 1992. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences. J. Clin. Invest. 90: 1290-1295.
21. Berti, J. A., M. E. Amaral, A. C. Boschero, V. S. Nunes, L. M. Harada, L. N. Castilho, and H. C. Oliveira. 2001. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice. Metabolism. 50: 530-536.
22. Montes, G. S., and E. H. Luque. 1988. Effects of ovarian steroids on vaginal smears in the rat. Acta Anat. (Basel). 133: 192-199.
23. Lichtman, A. H., S. K. Clinton, K Iiyama, P. W. Connelly, P. Libby, and M. I. Cybulsky. 1999. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler. Thromb. Vasc. Biol. 19: 1938-1944.
24. Marsh, M. M., V. R. Walker, L. K. Curtiss, and C. L. Banka. 1999. Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J. Lipid Res. 40: 893-900.
25. Paigen, B., A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68: 231-240.
26. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 353: 265-267.
27. McPherson, R., C. J. Mann, A. R. Tall, M. Hogue, L. Martin, R. W. Milne, and Y. L. Marcel. 1991. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler. Thromb. 11: 797-804.
28. Dobiasova, M., J. Stribrna, P. H. Pritchard, and J. J. Frohlich. 1992. Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middleaged and septuagenarian men. J. Lipid Res. 33: 1411-1418.
29. Albers, J.J., W. Pitman, G. Wolfbauer, M. C. Cheung, H. Kennedy, A. Y Tu, S. M. Marcovina, and B. Paigen. 1999. Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains. J. Lipid Res. 40: 295-301.
30. Jiao, S., T. G. Cole, R. T. Kitchens, B. Pfleger, and G. Schonfeld. 1990. Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography. Metabolism. 39: 155-160.
31. Damasceno, N. R., H. Goto, F. M. Rodrigues, C. T. Dias, F. S. Okawabata, D. S. Abdalla, and M. Gidlund. 2000. Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. J. Nutr. 130: 2641-2647.
32. Boschcov, P., L. Juliano, M. A. Juliano, and M. Gidlund. 2000. Development of a peptide-based ELISA for the detection of antibodies against oxidized low density lipoprotein (oxLDL). Atherosclerosis. 151: 224.
33. Brown, M. S., Y. K. Ho, and J. L. Goldstein. 1980. The cholesteryl ester cycle in macrophages foam cells. Continual hydrolysis and reesterification of cytoplasmatic cholesteryl ester. J. Biol. Chem. 255: 9344-9352.
34. Oliveira, H. C., L. Ma, R. Milne, S. M. Marcovina, A. Inazu, H. Mabuchi, and A. R. Tall. 1997. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. Arterioscler. Thromb. Vasc. Biol. 17: 1045-1052.
35. Lewis-Barned, N.J., W. H. Sutherland, R. J. Walker, H. L. Walker, S. A. De Jong, E. A. Edwards, and V. H. Markham. 1999. Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women. J. Clin. Endocrinol. Metab. 84: 3534-3538.
36. Sack, M. N., D. J. Rader, and R. O. Cannon 3rd. 1994. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343: 269-270.
37. Jiang, X., L. Masucci-Magoulas, J. Mar, M. Lin, A. Walsh, J. L. Breslow, and A. R. Tall. 1993. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. J. Biol. Chem. 268: 27406-27412.
38. Brown, M. S., P. T. Kovanen, and J. L. Goldstein. 1981. Regulation of plasma cholesterol by lipoprotein receptors. Science. 212: 628-635.
39. Tang, J. J., R. A. Srivastava, E. S. Krul, D. Baumann, B. A. Pfleger, R. T. Kitchens, and G. Schonfeld. 1991. In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice. J. Lipid Res. 32: 1571-1585.
40. Ness, G. C., and C. M. Chambers, 2000. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity. Proc. Soc. Exp. Biol. Med. 224: 8-19.
41. Yamashita, S., T. Maruyama, K. I. Hirano, N. Sakai, N. Nakajima, and Y. Matsuzawa. 2000. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia. Atherosclerosis. 152: 271-285.
42. Warden, C. H., C. C. Hedrick, J. H. Qiao, L. W. Castellani, and A. J. Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 261: 469-472.
43. Collet, X., A. R. Tall, H. Serajuddin, K. Guendouzi, L. Royer, H. Oliveira, R. Barbaras, X. C. Jiang, and O. L. Francone. 1999. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J. Lipid Res. 40: 1185-1193.
44. Landschulz, K. T., R. K, Pathak, A. Rigotti, M. Krieger, and H. H. Hobbs. 1996. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat, J. Clin. Invest. 98: 984-995.
45. Trigatti, B., A. Rigotti, and M. Krieger. 2000. The role of the highdensity lipoprotein receptor SR-BI in cholesterol metabolism. Curr. Opin. Lipidol. 11: 123-131.
46. Graf, G. A., K. L. Roswell, and E.J. Smart. 2001. 17β-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers. J. Lipid Res. 42: 1444-1449.
47. Keaney, J. F., G. T. Shwaery, Jr., A. Xu, R. J . Nicolosi, J. Loscalzo, T. L. Foxall, and J. A. Vita. 1994. 17β-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 89: 2251-2259.
48. Palinski, W., V. A, Ord, A. S. Plump, J. L. Breslow, D. Steinberg, and J. L. Witztum, 1994. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidationspecific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14: 605-616.
49. Tsimikas, S., W, Palinski, and J. L. Witztum. 2001. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21: 95-100.
50. Chiba, H., H. Akita, K. Kotani, T. Kanno, and M. Manabe. 1997. Complete cholesteryl ester transfer protein deficiency increases oxidized-LDL in plasma. Jpn. J. Clin. Pathol. 45: 55-57.
51. Castilho, L. N., H. C. Oliveira, P. M. Cazita, A. C. de Oliveira, A. Sesso, and E. C. Quintao. 2001. Oxidation of LDL enhances the cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester transfer rate to HDL, bringing on a diminished net transfer of cholesteryl ester from HDL to oxidized LDL. Clin. Chim. Acta. 304: 99-106.
52. Zhang, Z., S. Yamashita, K. Hirano, Y, Nakagawa-Toyama, A. Mat- suyama, M. Nishida, N. Sakai, M. Fukasawa, H. Arai, J. Miyagawa, and Y. Matsuzawa. 2001. Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport. Atherosclerosis. 159: 67-75.
53. Ishikawa, Y., K. Ito, Y. Akasaka, T. Ishii, T. Masuda, L. Zhang, Y. Akishima, H. Kiguchi, K. Nakajima, and Y. Hata. 2001. The distribution and production of cholesteryl ester transfer protein in the human aortic wall. Atherosclerosis. 156: 29-37.
54. Stein, Y., O. Stein, T. Olivecrona, and G. Halperin. 1985. Putative role of cholesteryl ester transfer protein in removal of cholesteryl ester from vascular interstitium, studied in a model system in cell culture. Biochim. Biophys. Acta. 834: 336-345.
55. Morton, R. E. 1988, Interaction of plasma-derived lipid transfer protein with macrophages in culture. J. Lipid Res. 29: 1367-1377.